| Abstrakt: |
This patent application discusses methods for treating retinal vasculopathies, such as diabetic macular edema and age-related macular degeneration. The methods involve administering various inhibitors and agonists to inhibit pathogenic neovascularization and vascular leak in the eye. The patent application provides specific examples of these inhibitors and agonists, such as antibodies, polypeptides, and small molecules. These methods have potential applications in the field of ophthalmology and may offer new treatment options for retinal vasculopathies. [Extracted from the article] |
